Aranda Pharma Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Onxeo, Black Diamond Therapeutics and Amolyt Pharma.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |||
Founding Date | Founding Date 2008 | Founding Date 1997 | Founding Date 2017 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Paris, FR HQ New York, US | Locations Cambridge, US HQ Toronto, CA New York, US Stony Brook, US | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 15815% increase | Employees 30 | Employees 6526% decrease | Employees 393% decrease |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 65 m | Valuation ($) 165 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $138.1m (FY, 2024) | Revenue (est.) €1.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income $31.9m (FY, 2024) | Net income (€20.3m) (FY, 2023) | Net income ($69.7m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 132.4m | Total funding raised N/A | Total funding raised $ 202.1m | Total funding raised $ 93.1m |
For sources of this data, please see the company profile
View Company Profiles
Onxeo
HQ
Paris, FR
Employees
30
Onxeo is biotechnology company that develops of drugs for oncology.
View company
Black Diamond Therapeutics
HQ
Cambridge, US
Employees
65↓ 26% decrease
Black Diamond Therapeutics is a biotechnology company.
View companyAmolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company